Aurobindo Pharma, Voltas and Trent clinch fresh 52-week high; here’s why – Upstox

Aurobindo Pharma, Voltas and Trent clinch fresh 52-week high; here’s why  UpstoxVoltas Q1 Results: Standalone net profit jumps 58% YoY to Rs 339.14 crore, revenue rises 45%  The Economic TimesVoltas shares zoom 9% to record high on solid Q1 earnings  MoneycontrolVolumes jump at Voltas Ltd counter  Business StandardVoltas Sees Q1 Net Profit Rocket 158% To ₹334 Cr, Shares Soar 9% To New 52-Week High  Benzinga India Aurobindo Pharma, Voltas and Trent clinch fresh 52-week high; here’s why  UpstoxVoltas Q1 Results: Standalone net profit jumps 58% YoY to Rs 339.14 crore, revenue rises 45%  The Economic TimesVoltas shares zoom 9% to record high on solid Q1 earnings  MoneycontrolVolumes jump at Voltas Ltd counter  Business StandardVoltas Sees Q1 Net Profit Rocket 158% To ₹334 Cr, Shares Soar 9% To New 52-Week High  Benzinga India  Top stories – Google News